Pursuant to Regulation 34(2)(f) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has submitted the Business Responsibility & Sustainability Report (BRSR) which forms part of the Annual Report for the financial year 2023-24.
The above information is a part of company’s filings submitted to BSE.